You’re in good company
Member Directory
From biotech startups and pharmaceutical companies to research institutions and healthcare leaders, our members represent the full spectrum of the industry, driving innovation, growth, and collaboration in the life sciences sector.
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. was created in 2011 as a spin-out of Cincinnati Children’s Hospital Medical Center (CCHMC), and has extensive expertise in protein development for applications in the lungs and pediatrics. The company’s first-to-market indication is the development of recombinant human surfactant protein-D (rhSP-D, AT-100) as a replacement protein therapy for the prevention of bronchopulmonary dysplasia (BPD) in premature infants. AT-100 is in advanced preclinical stage development and has received orphan designation for prevention of BPD in both the US and the EU.
(513) 770-9630
Hamilton County